174 related articles for article (PubMed ID: 14603692)
1. [Not just blood pressure counts. How well are hypertensive patients controlled?].
MMW Fortschr Med; 2003 Sep; 145(38):64. PubMed ID: 14603692
[No Abstract] [Full Text] [Related]
2. Safety and efficacy of olmesartan: an observational pooled-analysis of 156,682 hypertensive patients.
Scholze J; Schaefer A; Kreutz R
Expert Opin Drug Saf; 2011 Mar; 10(2):185-96. PubMed ID: 21254872
[TBL] [Abstract][Full Text] [Related]
3. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
4. Difficult-to-control hypertension: effects of olmesartan-based combination therapies.
de la Sierra A
J Hypertens; 2013 Mar; 31 Suppl 1():S1-2. PubMed ID: 23389082
[No Abstract] [Full Text] [Related]
5. Fixed-combination therapy to improve blood pressure control: experience with olmesartan-based therapy.
Tocci G; Volpe M
Expert Rev Cardiovasc Ther; 2011 Jul; 9(7):829-40. PubMed ID: 21809963
[TBL] [Abstract][Full Text] [Related]
6. [Risk oriented therapy of hypertension. Lowering blood pressure and risk].
MMW Fortschr Med; 2007 Nov; 149(46):53. PubMed ID: 18069196
[No Abstract] [Full Text] [Related]
7. Tribenzor for hypertension.
Med Lett Drugs Ther; 2010 Sep; 52(1346):70-1. PubMed ID: 20814402
[TBL] [Abstract][Full Text] [Related]
8. Two amlodipine/ARB combinations for hypertension.
Med Lett Drugs Ther; 2007 Dec; 49(1276):101-2. PubMed ID: 18084152
[No Abstract] [Full Text] [Related]
9. Olmesartan-based therapies: an effective way to improve blood pressure control and cardiovascular protection.
de la Sierra A; Volpe M
J Hypertens; 2013 Mar; 31 Suppl 1():S13-7. PubMed ID: 23389083
[TBL] [Abstract][Full Text] [Related]
10. [Fast and strong lowering of pressure. The newest sartan has passed the practice test].
MMW Fortschr Med; 2003 Oct; 145(44):45. PubMed ID: 14655509
[No Abstract] [Full Text] [Related]
11. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.
Chrysant SG
Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):887-95. PubMed ID: 19673666
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.
Mallion JM; Omboni S; Barton J; Van Mieghem W; Narkiewicz K; Panzer PK; Puig JG; Stefanadis C; Zweiker R;
Blood Press Suppl; 2011 Apr; 1():3-11. PubMed ID: 21091270
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of hypertension. A new rapidly effective AT1 blocker].
MMW Fortschr Med; 2002 Jun; 144(25):55. PubMed ID: 12136675
[No Abstract] [Full Text] [Related]
14. Lowering blood pressure in acute stroke: the SCAST trial.
Hankey GJ
Lancet; 2011 Feb; 377(9767):696-8. PubMed ID: 21316753
[No Abstract] [Full Text] [Related]
15. Efficacy of amlodipine and olmesartan medoxomil in patients with hypertension: the AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) study.
Punzi H; Neutel JM; Kereiakes DJ; Shojaee A; Waverczak WF; Dubiel R; Maa JF
Ther Adv Cardiovasc Dis; 2010 Aug; 4(4):209-21. PubMed ID: 20519261
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy for hypertension: focus on high-dose olmesartan medoxomil (40 mg) plus hydrochlorothiazide.
Rump LC; Sellin L
Expert Opin Pharmacother; 2010 Sep; 11(13):2231-42. PubMed ID: 20707758
[TBL] [Abstract][Full Text] [Related]
17. Olmesartan medoxomil: recent clinical and experimental acquisitions.
Destro M; Preti P; D'Ospina A; Christian Achiri NN; Ricci AR; Cagnoni F
Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1149-57. PubMed ID: 19689219
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy of a combination of amlodipine and olmesartan medoxomil ± hydrochlorothiazide in patients with hypertension stratified by age, race and diabetes status: a substudy of the COACH trial.
Oparil S; Chrysant SG; Melino M; Lee J; Karki S; Heyrman R
J Hum Hypertens; 2010 Dec; 24(12):831-8. PubMed ID: 20200547
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex).
Ogihara T; Ueshima K; Nakao K; Fukiyama K; Oba K; Yasuno S; Fujimoto A; Sato T; Matsuoka H; Saruta T;
Hypertens Res; 2011 Dec; 34(12):1295-301. PubMed ID: 21833000
[TBL] [Abstract][Full Text] [Related]
20. The clinical efficacy and tolerability of the angiotensin II-receptor antagonist losartan in Japanese patients with hypertension.
Ogihara T; Yoshinaga K
Blood Press Suppl; 1996; 2():78-81. PubMed ID: 8913545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
